Skip to main content
Multiple switches from infliximab to biosimilars effective and safe in IBD
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Multiple switches from infliximab to biosimilars effective and safe in IBD
User login
Username
Password
Reset your password
Concept
Lead
score
Inflammatory Bowel Disease
1
0.91
Biologic Therapy
0
0.83
Biosimilars
0
0.69
Remission
0
0.69
Dermatitis
0
0.21
C-Reactive Protein (CRP)
0
0.17
Id Reaction
0
0.17
Specialty
Lead
score
Gastroenterology
1
1
Pharmacist
0
0.98
Nursing
0
0.75
Dermatology
0
0.21
Family Medicine/Primary Care
0
0.21
Internal Medicine
0
0.21
Edit Tags